| P50 | author | Cristiana Catena | Q43271299 |
| | GianLuca Colussi | Q50636769 |
| | Stefan Pilz | Q90139195 |
| P2093 | author name string | Burkert Pieske | |
| | Leonardo A Sechi | |
| | Andreas Tomaschitz | |
| | Elisabeth Kraigher-Krainer | |
| | Nicolas D Verheyen | |
| | Marion Url-Michitsch | |
| P2860 | cites work | Differential value of left ventricular mass index and wall thickness in predicting cardiovascular prognosis: data from the PAMELA population | Q30773601 |
| | Cardiac dimensions are largely determined by dietary salt in patients with primary aldosteronism: results of a case-control study | Q35198525 |
| | Primary aldosteronism: cardiovascular, renal and metabolic implications | Q37100027 |
| | Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline | Q37190775 |
| | Recommendations for the evaluation of left ventricular diastolic function by echocardiography | Q37383745 |
| | Mineralocorticoid antagonists treatment versus surgery in primary aldosteronism. | Q37684883 |
| | Cardiovascular and renal damage in primary aldosteronism: outcomes after treatment. | Q37779717 |
| | The progression of hypertensive heart disease | Q37832070 |
| | Aldosterone and the heart: from basic research to clinical evidence | Q37957726 |
| | Aldosterone, organ damage and dietary salt. | Q38117211 |
| | Dietary Sodium, Aldosterone, and Left Ventricular Mass Changes During Long-Term Inhibition of the Renin-Angiotensin System | Q42870196 |
| | Diagnosis of secondary forms of hypertension. A comprehensive protocol | Q43908874 |
| | Excess aldosterone is associated with alterations of myocardial texture in primary aldosteronism | Q44053688 |
| | Association of aldosterone with left ventricular mass in hypertension: interaction with plasma fibrinogen levels | Q44155865 |
| | Aldosterone induces a vascular inflammatory phenotype in the rat heart | Q44182980 |
| | Relative long-term effects of spironolactone in conjunction with an angiotensin-converting enzyme inhibitor on left ventricular mass and diastolic function in patients with essential hypertension | Q44250876 |
| | Serum lipoprotein(a) concentrations and alcohol consumption in hypertension: possible relevance for cardiovascular damage | Q44303893 |
| | Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study | Q44601096 |
| | Active renin versus plasma renin activity to define aldosterone-to-renin ratio for primary aldosteronism | Q44838802 |
| | Prognostic significance of left ventricular mass change during treatment of hypertension | Q45152749 |
| | Insulin hypersecretion: a distinctive feature between essential and secondary hypertension | Q45937499 |
| | Independent relations of left ventricular structure with the 24-hour urinary excretion of sodium and aldosterone. | Q45937843 |
| | Aldosterone and left ventricular hypertrophy in Afro-Caribbean subjects with low renin hypertension | Q46394166 |
| | Inappropriate left ventricular mass in patients with primary aldosteronism. | Q46470689 |
| | Mineralocorticoid receptor activation and oxidative stress | Q46960438 |
| | Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism | Q46983529 |
| | Effects of spironolactone during an angiotensin II receptor blocker treatment on the left ventricular mass reduction in hypertensive patients with concentric left ventricular hypertrophy | Q48463620 |
| | Serum aldosterone and its relationship to left ventricular structure and geometry in patients with preserved left ventricular ejection fraction. | Q51423999 |
| | Plasma aldosterone and left ventricular diastolic function in treatment-naïve patients with hypertension: tissue-Doppler imaging study. | Q52868479 |
| | 2007 Guidelines for the Management of Arterial Hypertension | Q56970780 |
| | Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardio | Q57217547 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | left ventricular hypertrophy | Q1628627 |
| P304 | page(s) | 303-310 | |
| P577 | publication date | 2015-07-10 | |
| P1433 | published in | Journal of Clinical Hypertension | Q15762840 |
| P1476 | title | Association of Post-Saline Load Plasma Aldosterone Levels With Left Ventricular Hypertrophy in Primary Hypertension | |
| P478 | volume | 29 | |